Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 100mg | $49.99$30.00 | $0.30/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| GHK052614100N | Apr 2026 | 99.7% | Janoshik Analytical | Endotoxin | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. GHK-Cu is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Verified Peptides sell GHK-Cu?
Yes — Verified Peptides currently lists GHK-Cu in 1 variant starting at $30.00 ($0.30/mg).
Is Verified Peptides's GHK-Cu third-party tested?
Yes — Disclosed Labs has indexed 21 Certificates of Analysis for Verified Peptides's GHK-Cu, with the most recent showing 99.7% purity. Verified Peptides holds an overall trust grade of C (79/100) across all 364 COAs on file.
What is Verified Peptides's trust grade for GHK-Cu?
Verified Peptides has an overall Disclosed Labs trust grade of C (79/100), computed from 364 COAs across all peptides. The most recent GHK-Cu COA was issued by Janoshik Analytical.
Where is the cheapest GHK-Cu?
As of the latest data, Sunrise Bioresearch offers GHK-Cu at $0.09/mg — compare with Verified Peptides's listing at $0.30/mg. See the full GHK-Cu price comparison.
Is GHK-Cu legal to buy?
GHK-Cu is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| GHK02261350M | Mar 2026 | 99.8% | Janoshik Analytical | Endotoxin | Confirmed | View |
| GHK022613100M | Feb 2026 | 99.8% | Janoshik Analytical | Endotoxin | Unverified | View |
| 01-25-12100L | Dec 2025 | 99.8% | Janoshik Analytical | — | Confirmed | View |
| 09-25-11100K | Sep 2025 | 100.0% | Janoshik Analytical | — | Unverified | View |
| 06-25-10100J | Jul 2025 | 99.9% | Janoshik Analytical | — | Unverified | View |
| 06-25-1050J | Jun 2025 | 99.9% | Janoshik Analytical | — | Unverified | View |
| 12-24-0910I | Feb 2025 | 100.0% | Janoshik Analytical | Endotoxin | Unverified | View |
| 09-214-0810 | Oct 2024 | 99.9% | Janoshik Analytical | Endotoxin | Unverified | View |
| 240302B | Apr 2024 | 100.0% | Janoshik Analytical | — | Unverified | View |
| 20224F | Feb 2024 | 99.8% | Janoshik Analytical | — | Unverified | View |
| 33168E | Jul 2023 | 100.0% | Janoshik Analytical | — | Unverified | View |
| 331686 | Jul 2023 | 100.0% | Unknown | — | Unverified | View |
| 64882D | May 2023 | 100.0% | Janoshik Analytical | — | Unverified | View |
| — | Nov 2022 | 99.8% | Unknown | — | Unverified | View |
| 86653A | Nov 2022 | 99.8% | Unknown | — | Unverified | View |
| 98422C | May 2022 | 100.0% | Unknown | — | Unverified | View |
| 42734B | Nov 2021 | 99.6% | Janoshik Analytical | — | Unverified | View |
| — | Nov 2021 | 99.6% | Janoshik Analytical | Heavy metals | Unverified | View |
| 65413A | Mar 2021 | 98.5% | Janoshik Analytical | — | Unverified | View |
| — | — | 99.6% | Janoshik Analytical | Endotoxin | Unverified | View |